Skip to main content
OpenTrials

Clinical trial condition

Lupus Nephritis

Explore clinical trials studying Lupus Nephritis. Study availability and eligibility vary by location and protocol.

162 public trials 48 recruiting studies
Refine in advanced search Browse all conditions

Lupus Nephritis trial results

Enrolling by invitation

A Study of KITE-363 in Participants With Refractory Autoimmune Diseases

NCT07038447

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +21 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University Stanford, California, United States
  • Tampa General Hospital Cancer Institute Tampa, Florida, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Active, not recruiting

A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

NCT06581198

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • University Of Alabama Birmingham, Alabama, United States
  • Loma Linda University San Bernardino, California, United States
  • UCSF San Francisco, California, United States
  • Sutter Health Network San Pablo, California, United States
View all 107 locations
View Trial Details
Active, not recruiting

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

NCT05126277

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • University Of Alabama Birmingham, Alabama, United States
  • Advanced Medical Research La Palma, California, United States
  • University of California Irvine Orange, California, United States
  • Kaiser Permanente San Diego, California, United States
View all 147 locations
View Trial Details
Active, not recruiting

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

NCT05798117

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Pessac, France
  • Novartis Investigative Site Strasbourg, France
View Trial Details

Related conditions